Receptors for hyaluronic acid and poliovirus: A combinatorial role in glioma invasion?

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Maherally, Zaynah ^a   Smith, James R ^a   An, Qian ^a   Pilkington, Geoffrey J ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD155 ANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; HERMES ANTIGEN; HYALURONIC ACID; LAMININ; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN CDC42; RAC1 PROTEIN; RAC2 PROTEIN; RAC3 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5; VIRUS RECEPTOR; VITRONECTIN RECEPTOR; ACTIN; BLOCKING ANTIBODY; INTEGRIN; POLIOVIRUS RECEPTOR;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MOTILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE MICROSCOPY; GENE SILENCING; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; CELL MOTION; CELL PROLIFERATION; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PATHOLOGY; POLIOMYELITIS VIRUS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

ACTINS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; HYALURONIC ACID; INTEGRINS; NEOPLASM INVASIVENESS; POLIOVIRUS; PROTEIN TRANSPORT; RECEPTORS, VIRUS; RHO GTP-BINDING PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84857182500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030691     Document Type: Article

References (52)

1. Westphal M, Lamszus K, (2011) The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci 12: 495-508.
2. Pilkington GJ, (1994) Tumour cell migration in the central nervous system. Brain Pathol 4: 157-66.
3. Bolteus AJ, Berens ME, Pilkington GJ, (2001) Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep1: 225-32.
4. D'Abaco GM, Kaye AH, (2007) Integrins: molecular determinants of glioma invasion. J Clin Neurosci 14: 1041-8.
5. Pilkington GJ, (1996) The role of the extracellular matrix in neoplastic glial invasion of the nervous system. Braz J Med Biol Res 29: 1159-72.
6. Christofori G, (2006) New signals from the invasive front. Nature 441: 444-450.
7. Bogenrieder T, Herlyn M, (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22: 6524-36.
8. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, et al. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24.
9. Frank S, Rihs HP, Stöcker W, Müller J, Dumont B, et al. (1996) Combined detection of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry in primary human brain tumors and brain metastases. Biochem Biophys Res Commun 222: 794-801.
10. Pilkington GJ, (2005) Cancer stem cells in the mammalian central nervous system. Cell Prolif 38: 423-33.
11. Wiranowska M, Ladd S, Moscinski LC, Hill B, Haller E, et al. (2010) Modulation of hyaluronan production by CD44 positive glioma cells. Int J Cancer 127: 532-542.
12. Park JB, Kwak HJ, Lee SH, (2008) Role of hyaluronan in glioma invasion. Cell Adh Migr 2: 202-207.
13. Knudson W, Biswas C, Li X-Q, Nemec RE, Toole BP, (1989) The role and regulation of tumour-associated hyaluronan. Ciba Found Symp 143: 150-9.
14. Stern R, Shuster S, Wiley TS, Formby B, (2001) Hyaluronidase can modulate expression of CD44. Exp Cell Res 266: 167-76.
15. Okamoto I, Tsuiki H, Kenyon LC, Godwin AK, Emlet DR, et al. (2002) Proteolytic Cleavage of the CD44 adhesion molecule in multiple human tumours. Am J Pathol 160: 441-7.
16. Akiyama Y, Jung S, Salhia B, Lee S, Hubbard S, et al. (2001) Hyaluronate receptors mediating glioma cell migration and proliferation. J Neurooncol 5: 115-27.
17. Wiranowska M, Ladd S, Smith SR, Gottschall PE, (2006) CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma. Brain Cell Biol 35: 159-72.
18. Lange R, Peng X, Wimmer E, Lipp M, Bernhardt G, (2001) The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology 285: 218-27.
19. Goetz C, Dobrikova E, Shveygert M, Dobrikov M, Gromeier M, (2011) Oncolytic poliovirus against malignant glioma. Future Virol 6: 1045-1058.
20. Sloan KE, Eustace BK, Stewart JK, Zehetmeier C, Torella C, et al. (2004) CD155/PVR plays a key role in cell motility during tumour cell invasion and migration. BMC Cancer 4: 73.
21. Sloan KE, Eustace BK, Stewart JK, Zehetmeier C, Torella C, et al. (2005) CD155 enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics. Cancer Res 65: 10930-7.
22. Enloe BM, Jay DG, (2011) Inhibition of Necl-5 (CD155/PVR) reduces glioblastoma dispersal and decreases MMP-2 expression and activity. J Neurooncol 102: 225-235.
23. Freistadt MS, Eberle KE, (1997) Physical association between CD155 and CD44 in human monocytes. Mol Immunol 34: 1247-57.
24. Shepley MP, Racaniello VR, (1994) A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44. J Virol 68: 1301-8.
25. Giese A, Loo MA, Tran D, Haskett SW, Coons BME, (1996) Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67: 275-82.
26. Pilkington GJ, Akinwunmi J, Ognjenovic N, Rogers JP, (1993) Differential binding of anti-CD44 on human gliomas in vitro. Neuroreport 4: 259-62.
27. Bernhardt G, Bibb JA, Bradley J, Wimmer E, (1994) Molecular characterization of the cellular receptor for poliovirus. Virology 199: 105-13.
28. Luna EJ, Hitt AL, (1992) Cytoskeleton-plasma membrane interactions. Science 258: 955-64.
29. Merzak A, Koochekpour S, Pilkington GJ, (1994) CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54: 3988-92.
30. Sneath RJ, Mangham DC, (1998) The normal structure and function of CD44 and its role in neoplasia. Mol Path 51: 191-200.
31. Okada H, Yoshida J, Sokabe M, Wakabayashi T, Hagiwara M, (1996) Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int J Cancer 66: 255-60.
32. Goldbrunner RH, Bernstein JJ, Tonn JC, (1999) Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir 141: 295-305.
33. Szeto MD, Chakraborty G, Hadley J, Rockne R, Muzi M, et al. (2009) Quantitative Metrics of Net Proliferation and Invasion Link Biological Aggressiveness Assessed by MRI with Hypoxia Assessed by FMISO-PET in Newly Diagnosed Glioblastomas. Cancer Res 69: 4502-9.
34. Vikesaa J, Hansen TV, Jønson L, Borup R, Wewer UM, et al. (2006) RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J 25: 1456-68.
35. Schimitz AA, Govek EE, Bottner B, Van Aelst L, (2000) Rho GTPases: signaling, migration and invasion. Exp Cell Res 261: 1-12.
36. Chiquet-Ehrismann R, Hagios C, Schenk S, (1995) The complexity in regulating the expression of tenascins. Bioessays 17: 873-8.
37. Giese A, Loo MA, Rief MD, Tran N, Berens ME, (1995) Substrates for astrocytoma invasion. Neurosurgery 37: 294-301.
38. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B, (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1301-13.
39. Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y, (2002) CD44 in cancer. Crit Rev Clin Lab Sci 39: 527-79.
40. Gladson CL, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA, (1995) Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumours. J Cell Sci 108: 947-56.
41. Merzak A, Pilkington GJ, (1997) Molecular and cellular pathology of intrinsic brain tumours. Cancer Metastasis Rev 16: 155-77.
42. Desgrosellier JS, Cheresh DA, (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10: 9-22.
43. Hu B, Jarzynka MJ, Guo P, Imanishi Y, Schlaepfer DD, et al. (2006) Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 66: 775-83.
44. Claes A, Idema AJ, Wesseling P, (2007) Diffuse glioma growth: a guerilla war. Acta neuropathol 114: 443-58.
45. Siegelman MH, Stanescu D, Estess P, (2000) The CD44-initiated pathway of T-cell extravasation uses VLA-4 but LFA-1 for firm adhesion. J Clin Invest 105: 683-91.
46. Nandi A, Estess P, Siegelman M, (2004) Biomolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 20: 455-65.
47. Maidment SL, (1997) The cytoskeleton and brain tumour cell migration. Anticancer Res 17: 4145-9.
48. Raftopoulou M, Hall A, (2004) Cell Migration: Rho GTPases lead the way. Dev Biol 265: 23-32.
49. Banyard J, Anand-Apte B, Symons M, Zetter BR, (2000) Motility and invasion are differentially modulated by Rho family GTPases. Oncogene 19: 580-91.
50. Okamoto I, Kawano Y, Matsumoto M, Suga M, Kaibuchi K, et al. (1999) Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J Biol Chem 274: 25525-34.
51. Murai T, Miyazaki Y, Nishinakamura H, Sugahara KN, Miyauchi T, et al. (2004) Engagement of CD44 promotes Rac Activation and CD44 Cleavage during Tumour Cell Migration. J Biol Chem 279: 4541-50.
52. Birks SM, Danquah JO, King L, Vlasak R, Gorecki DC, et al. (2011) Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma. Neuro Oncol 13: 950-60.